Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Clin Endocrinol Metab ; 80(8): 2490-4, 1995 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-7629248

RESUMO

Familial male-limited precocious puberty (FMPP) is an autosomal dominant gonadotropin-independent disorder. Affected males generally develop signs of precocious puberty in early childhood. They typically show Leydig cell hyperplasia and increased testosterone production typical for their age, whereas circulating LH concentrations remain prepubertal. Several dominant point mutations of the LH receptor gene were identified in pedigrees with familial male-limited precocious puberty and were shown to cosegregate with the disease. Here we report a novel heterozygote point mutation in the LH receptor gene of a Brazilian boy with gonadotropin-independent precocious puberty. This mutation substitutes alanine 568 with valine at the carboxyterminus of the third cytosolic loop of the LH receptor. The unoccupied mutant receptors confer constitutive activation of adenyl cyclase activity when expressed in COS-7 cells, resulting in 4-fold higher cAMP concentrations over baseline compared with cells expressing an equivalent number of wild-type receptors. The affinity of the mutant receptors to 125I-labeled human LH was not altered compared with the wild type. Mutations of the homologue alanine residue in the alpha 1-adrenergic (in vitro), FSH (in vitro), and TSH (naturally occurring) receptors also result in constitutive adenyl cyclase activation, suggesting that this alanine residue is crucial for signal transduction and a potential site for upregulatory/oncogenic mutations in G-protein coupled receptors.


Assuntos
Hormônio Foliculoestimulante/sangue , Hormônio Luteinizante/sangue , Mutação Puntual , Puberdade Precoce/genética , Receptores do LH/genética , Alanina , Sequência de Aminoácidos , Androgênios/sangue , Animais , Sequência de Bases , Linhagem Celular , Pré-Escolar , Chlorocebus aethiops , AMP Cíclico/metabolismo , DNA/genética , Primers do DNA , Hormônio Foliculoestimulante/metabolismo , Triagem de Portadores Genéticos , Hormônio Liberador de Gonadotropina/farmacologia , Humanos , Hormônio Luteinizante/metabolismo , Hormônio Luteinizante/farmacologia , Masculino , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Conformação Proteica , Puberdade Precoce/sangue , Receptores do LH/biossíntese , Receptores do LH/química , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/química , Valores de Referência , Transfecção , Valina
2.
Nutr Rev ; 57(9 Pt 2): S41-5, 1999 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10568350

RESUMO

The body of knowledge about plants, herbs, and spices and their respective and collective roles in promoting human health is modest. Flavonoids in tea and anthocyanins in tart cherries were presented as examples of how to move forward in understanding active compounds. Dietary compounds, their roles in maintaining human health, and their interactions with established nutrients were determined to be short-term research priorities.


Assuntos
Antocianinas/uso terapêutico , Flavonoides/uso terapêutico , Fenômenos Fisiológicos da Nutrição , Fitoterapia , Plantas Medicinais/metabolismo , Plantas Medicinais/uso terapêutico , Saúde , Humanos , Pesquisa , Estados Unidos
3.
Acad Radiol ; 8(9): 915-8, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11724048

RESUMO

PURPOSE: Radiology resident interpretation of computed tomographic (CT) scans at academic institutions often guides management of cases of suspected acute appendicitis in the emergency department. The purpose of this study was to compare resident and faculty interpretation of CT scans obtained for acute appendicitis. MATERIALS AND METHODS: From December 16, 1999, to July 13, 2000, CT was performed in 103 consecutive patients between the hours of 9:00 PM and 8:00 AM who were suspected of having acute appendicitis. The authors compared the residents' preliminary written interpretations with both the final reports written by the faculty and the surgical findings. The faculty interpreting the CT scans were aware of resident interpretations but were not aware that a study was being conducted. RESULTS: The final faculty interpretation and the preliminary resident interpretation were identical in 96 of the 103 patients (93%; 95% confidence interval: 87.8%, 97.2%). In only one patient was a scan originally interpreted as negative interpreted as positive by the faculty member. Clinically, the patient did not have acute appendicitis, and surgery was not perforrmed. CONCLUSION: In the diagnosis of acute appendicitis, image interpretations made by adequately trained radiology residents can be expected to closely match those of the radiology faculty, and the practice of after-hours interpretation of such studies by radiology residents is safe.


Assuntos
Apendicite/diagnóstico por imagem , Internato e Residência , Radiologia/educação , Doença Aguda , Adolescente , Adulto , Idoso , Criança , Diagnóstico Diferencial , Serviço Hospitalar de Emergência , Feminino , Humanos , Masculino , Corpo Clínico Hospitalar , Pessoa de Meia-Idade , Radiografia
4.
J Pediatr Endocrinol Metab ; 10(5): 499-503, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9401906

RESUMO

Male sexual precocity is defined as the development of secondary sexual characteristics before 9 years of age. It can be classified as gonadotropin-dependent precocious puberty (GnDP) or gonadotropin-independent precocious puberty (GnIP) and sometimes the differential diagnosis between these entities is difficult. To determine whether long-acting GnRH agonists (GnRH-a) are effective in differential diagnosis of male precocious puberty, we measured gonadotropins and testosterone levels 30 days after a single administration of depot GnRH-a (triptorelin, gosereline or leuprolide) in 10 boys with sexual precocity of different etiologies. Testosterone levels 30 days after depot GnRH-a were in the prepubertal range in patients with GnDP but not in GnIP. We conclude that measurement of testosterone levels 30 days after long-acting GnRH-a is effective in the differential diagnosis of male sexual precocity.


Assuntos
Hormônio Liberador de Gonadotropina/agonistas , Puberdade Precoce/diagnóstico , Criança , Pré-Escolar , Diagnóstico Diferencial , Hormônio Foliculoestimulante/sangue , Gosserrelina , Humanos , Lactente , Leuprolida , Hormônio Luteinizante/sangue , Masculino , Puberdade Precoce/etiologia , Testosterona/sangue , Pamoato de Triptorrelina
5.
Arch Dis Child ; 80(3): 231-4, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10325702

RESUMO

The gonadotropin releasing hormone (GnRH) secreting hypothalamic hamartoma (HH) is a congenital malformation consisting of a heterotopic mass of nervous tissue that contains GnRH neurosecretory neurons attached to the tuber cinereum or the floor of the third ventricle. HH is a well recognised cause of gonadotropin dependent precocious puberty (GDPP). Long term data are presented on eight children (five boys and three girls) with GDPP due to HH. Physical signs of puberty were observed before 2 years of age in all patients. At presentation with sexual precocity, the mean height standard deviation (SD) for chronological age was +1.60 (1.27) and the mean height SD for bone age was -0.92 (1.77). Neurological symptoms were absent at presentation and follow up. The hamartoma diameter ranged from 5 to 18 mm and did not change in six patients who had magnetic resonance imaging follow up. All patients were treated clinically with GnRH agonists (GnRH-a). The duration of treatment varied from 2.66 to 8.41 years. Seven of the eight children had satisfactory responses to treatment, shown by regression of pubertal signs, suppression of hormonal levels, and improvement of height SD for bone age and predicted height. One patient had a severe local reaction to GnRH-a with failure of hormonal suppression and progression of pubertal signs. It seems that HH is benign and that GnRH-a treatment provides satisfactory and safe control for most children with GDPP due to HH.


Assuntos
Hormônio Liberador de Gonadotropina/antagonistas & inibidores , Hormônio Liberador de Gonadotropina/metabolismo , Hamartoma/complicações , Doenças Hipotalâmicas/complicações , Puberdade Precoce/etiologia , Antineoplásicos Hormonais/uso terapêutico , Criança , Pré-Escolar , Feminino , Seguimentos , Gosserrelina/uso terapêutico , Hamartoma/sangue , Hamartoma/tratamento farmacológico , Humanos , Doenças Hipotalâmicas/sangue , Doenças Hipotalâmicas/tratamento farmacológico , Leuprolida/uso terapêutico , Imageamento por Ressonância Magnética , Masculino , Puberdade Precoce/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa